BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lucero Y, Vidal R, O'Ryan G M. Norovirus vaccines under development. Vaccine 2018;36:5435-41. [PMID: 28668568 DOI: 10.1016/j.vaccine.2017.06.043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Morales-Hernández S, Ugidos-Damboriena N, López-Sagaseta J. Self-Assembling Protein Nanoparticles in the Design of Vaccines: 2022 Update. Vaccines (Basel) 2022;10:1447. [PMID: 36146525 DOI: 10.3390/vaccines10091447] [Reference Citation Analysis]
2 Shanthappa PM, Suravajhala R, Suravajhala P, Kumar G, Melethadathil N. In silico based multi-epitope vaccine design against norovirus. J Biomol Struct Dyn 2022;:1-11. [PMID: 35916029 DOI: 10.1080/07391102.2022.2105400] [Reference Citation Analysis]
3 Tsai H, Yune P, Rao M. Norovirus disease among older adults. Therapeutic Advances in Infection 2022;9:204993612211367. [DOI: 10.1177/20499361221136760] [Reference Citation Analysis]
4 Nagamani K, Rani M, Reddy V, Rao P, Rajyalakshmi S, Pakalapaty S. Molecular epidemiology of norovirus variants detected in children under five years of age in Hyderabad, India. Indian J Med Microbiol 2021:S0255-0857(21)04720-4. [PMID: 34856323 DOI: 10.1016/j.ijmmb.2021.11.012] [Reference Citation Analysis]
5 Kõivumägi K, Geller J, Toompere K, Soeorg H, Kallas E, Jõgeda EL, Huik K, Lutsar I. Norovirus strains among children aged 0-18 years hospitalized with acute gastroenteritis in Estonia 2015-2016. J Med Virol 2021. [PMID: 34854093 DOI: 10.1002/jmv.27495] [Reference Citation Analysis]
6 Yasmin F, Ali SH, Ullah I. Norovirus outbreak amid COVID-19 in the United Kingdom; priorities for achieving control. J Med Virol 2021. [PMID: 34713915 DOI: 10.1002/jmv.27426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lo M, Mitra S, De P, Banerjee A, Deb AK, Miyoshi SI, Manna A, Ghosh SK, Okamoto K, Dutta S, Chawla-Sarkar M. Genetic characterization and evolutionary analysis of norovirus genotypes circulating among children in eastern India during 2018-2019. Arch Virol 2021. [PMID: 34383167 DOI: 10.1007/s00705-021-05197-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ludwig-Begall LF, Mauroy A, Thiry E. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses 2021;13:1541. [PMID: 34452406 DOI: 10.3390/v13081541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
9 Rogawski McQuade ET, Liu J, Kang G, Kosek MN, Lima AAM, Bessong PO, Samie A, Haque R, Mduma ER, Shrestha S, Leite JP, Bodhidatta L, Iqbal N, Page N, Kiwelu I, Bhutta Z, Ahmed T, Houpt ER, Platts-Mills JA. Protection From Natural Immunity Against Enteric Infections and Etiology-Specific Diarrhea in a Longitudinal Birth Cohort. J Infect Dis 2020;222:1858-68. [PMID: 31984416 DOI: 10.1093/infdis/jiaa031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
10 Dey SK, Sharif N, Billah B, Siddique TT, Islam T, Parvez AK, Talukder AA, Phan T, Ushijima H. Molecular epidemiology and genetic diversity of norovirus infection in children with acute gastroenteritis in Bangladesh, 2014-2019. J Med Virol 2021;93:3564-71. [PMID: 33386771 DOI: 10.1002/jmv.26772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Grytdal S, Chavers TP, Mattison CP, Tate JE, Hall AJ. Vaccines Against Viral Gastroenteritis. Encyclopedia of Virology 2021. [DOI: 10.1016/b978-0-12-814515-9.00090-4] [Reference Citation Analysis]
12 Chen YL, Huang CT. Establishment of a two-step purification scheme for tag-free recombinant Taiwan native norovirus P and VP1 proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2020;1159:122357. [PMID: 32920339 DOI: 10.1016/j.jchromb.2020.122357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Solis-Sanchez D, Rivera-Piza A, Lee S, Kim J, Kim B, Choi JB, Kim YW, Ko GP, Song MJ, Lee SJ. Antiviral Effects of Lindera obtusiloba Leaf Extract on Murine Norovirus-1 (MNV-1), a Human Norovirus Surrogate, and Potential Application to Model Foods. Antibiotics (Basel) 2020;9:E697. [PMID: 33066532 DOI: 10.3390/antibiotics9100697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Tarr GAM, Pang XL, Zhuo R, Lee BE, Chui L, Ali S, Vanderkooi OG, Michaels-Igbokwe C, Tarr PI, MacDonald SE, Currie G, MacDonald J, Kim K, Freedman SB. Attribution of Pediatric Acute Gastroenteritis Episodes and Emergency Department Visits to Norovirus Genogroups I and II. J Infect Dis 2021;223:452-61. [PMID: 32614406 DOI: 10.1093/infdis/jiaa391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fernandes RS, Freire MCLC, Bueno RV, Godoy AS, Gil LHVG, Oliva G. Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses. Viruses 2020;12:E598. [PMID: 32486283 DOI: 10.3390/v12060598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Hofmann FM, Olawumi E, Michaelis M, Stößel U, Hofmann F. Significance of norovirus in occupational health: a review of published norovirus outbreaks in Central and Northern Europe. Int Arch Occup Environ Health 2020;93:911-23. [PMID: 32358716 DOI: 10.1007/s00420-020-01543-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gelaw A, Pietsch C, Mann P, Liebert UG. Molecular detection and characterisation of sapoviruses and noroviruses in outpatient children with diarrhoea in Northwest Ethiopia. Epidemiol Infect 2019;147:e218. [PMID: 31364546 DOI: 10.1017/S0950268819001031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
18 Chen W, Kang T, Yuan R, Shao C, Jing S. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine. Biotechnol Lett 2020;42:1211-8. [PMID: 32088791 DOI: 10.1007/s10529-020-02837-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Bozkurt H, Phan-Thien KY, van Ogtrop F, Bell T, McConchie R. Outbreaks, occurrence, and control of norovirus and hepatitis a virus contamination in berries: A review. Crit Rev Food Sci Nutr 2021;61:116-38. [PMID: 32008374 DOI: 10.1080/10408398.2020.1719383] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
20 Hofmann FM, Michaelis M, Stößel U, Hofmann F. [On Statistical Underreporting of Norovirus-Infections: Insights from Register Data of Two Local Public Health Authorities]. Gesundheitswesen 2021;83:357-62. [PMID: 31962363 DOI: 10.1055/a-1076-8128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Azegami T, Yuki Y, Kiyono H. Plant-Based Mucosal Vaccine Delivery Systems. Mucosal Vaccines 2020. [DOI: 10.1016/b978-0-12-811924-2.00020-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Guo J, Douangamath A, Song W, Coker AR, Chan AE, Wood SP, Cooper JB, Resnick E, London N, Delft FV. In crystallo-screening for discovery of human norovirus 3C-like protease inhibitors. Journal of Structural Biology: X 2020;4:100031. [DOI: 10.1016/j.yjsbx.2020.100031] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Hungerford D, Jere KC, Bar-Zeev N, Harris JP, Cunliffe NA, Iturriza-Gómara M. Epidemiology and genotype diversity of norovirus infections among children aged <5 years following rotavirus vaccine introduction in Blantyre, Malawi. J Clin Virol 2020;123:104248. [PMID: 31881509 DOI: 10.1016/j.jcv.2019.104248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Giancotti G, Rigo I, Pasqualetto G, Young MT, Neyts J, Rocha-Pereira J, Brancale A, Ferla S, Bassetto M. A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase. Sci Rep 2019;9:18413. [PMID: 31804593 DOI: 10.1038/s41598-019-54903-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Malm M, Vesikari T, Blazevic V. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization. Viruses 2019;11:E1018. [PMID: 31684058 DOI: 10.3390/v11111018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Tan M, Jiang X. Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development. Pharmaceutics 2019;11:E472. [PMID: 31547456 DOI: 10.3390/pharmaceutics11090472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
27 Fischer TK, Rasmussen LD, Fonager J. Taking gastro-surveillance into the 21st century. J Clin Virol 2019;117:43-8. [PMID: 31176211 DOI: 10.1016/j.jcv.2019.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Gibson KE, D'souza DH, Hall AJ. Foodborne Viral Pathogens. Food Microbiology 2019. [DOI: 10.1128/9781555819972.ch23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Malm M, Diessner A, Tamminen K, Liebscher M, Vesikari T, Blazevic V. Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana. Pharmaceutics 2019;11:E229. [PMID: 31083495 DOI: 10.3390/pharmaceutics11050229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
30 Annamalai T, Lu Z, Jung K, Langel SN, Tuggle CK, Dekkers JCM, Waide EH, Kandasamy S, Saif LJ. Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection. Virus Res 2019;267:21-5. [PMID: 31054932 DOI: 10.1016/j.virusres.2019.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
31 Haynes J, Perry V, Benson E, Meeks A, Watts G, Watkins H, Braun R. In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination. Viruses 2019;11:E392. [PMID: 31035476 DOI: 10.3390/v11050392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 Malm M, Hyöty H, Knip M, Vesikari T, Blazevic V. Development of T cell immunity to norovirus and rotavirus in children under five years of age. Sci Rep 2019;9:3199. [PMID: 30824789 DOI: 10.1038/s41598-019-39840-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
33 Malm M, Tamminen K, Vesikari T, Blazevic V. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera. Viral Immunology 2018;31:649-57. [DOI: 10.1089/vim.2018.0115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
34 Chen YL, Chang PJ, Huang CT. Small P particles formed by the Taiwan-native norovirus P domain overexpressed in Komagataella pastoris. Appl Microbiol Biotechnol 2018;102:9707-18. [PMID: 30187100 DOI: 10.1007/s00253-018-9331-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Mattison CP, Cardemil CV, Hall AJ. Progress on norovirus vaccine research: public health considerations and future directions. Expert Rev Vaccines 2018;17:773-84. [PMID: 30092671 DOI: 10.1080/14760584.2018.1510327] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 11.6] [Reference Citation Analysis]
36 Stavis SM, Fagan JA, Stopa M, Liddle JA. Nanoparticle Manufacturing – Heterogeneity through Processes to Products. ACS Appl Nano Mater 2018;1:4358-85. [DOI: 10.1021/acsanm.8b01239] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
37 Hwang HS, Puth S, Tan W, Verma V, Jeong K, Lee SE, Rhee JH. More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization. Hum Vaccin Immunother 2018;14:2194-202. [PMID: 29781755 DOI: 10.1080/21645515.2018.1472185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
38 McIntosh EDG. Healthcare-associated infections: potential for prevention through vaccination. Ther Adv Vaccines Immunother 2018;6:19-27. [PMID: 29998218 DOI: 10.1177/2515135518763183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]